A rapid and highly effective non-invasive treatment for stroke related paralysis has been developed and tested. Over 1,200 patients have been treated between 1984 and 2001. In a statistical survey of 289 consecutive cases from 1997 through April 2001, 95% of the treated patients recovered total or near-total normal functioning within 2 to 3 months after commencing treatment. The majority of patients constituted extreme cases in that they were:
- Suffering from severe paralysis
- Over 50 years of age
- Receiving treatment several months or years after the onset of the stroke.
Additionally, 100% of patients who received treatment within two weeks of paralysis recovered fully. The treatment is also highly effective even if administered months or years after the onset of the stroke.
The treatment principally consists of three distinct but complementary elements:
- Conventional FDA approved drug treatments. The dosages of the drugs are tightly controlled in a unique manner so as to achieve an optimal result for each individual patient.
- A rigorous stroke rehab physical therapy regimen.
- Complimentary self-administered herbal supplements and holistic natural health products which are unregulated by FDA.
The three elements are combined in two daily sessions approximately 8 to 12 hours apart. Each session lasts approximately 60 minutes. No side effects have been observed to date in the 289 cases treated.
Over 4 million people in the USA suffer from stroke related paralysis. Each year this number increases by approximately 300,000 people. An effective treatment for stroke has extraordinary global implications both from a humanitarian as well as socio-economic perspective.
The treatment has been reviewed by a team of independent and neutral medical experts. Reviewers comprised of senior researchers & senior certified doctors with no shares in the company or other form of payment or compensation. Reviewers were unrelated and reviewed the treatment independently of other members.
Paralysis Sciences Inc. is a Canadian corporation. We welcome collaboration with medical universities, hospitals and clinics worldwide.
Licensing opportunities are also avaiable on a limited basis in several countries.